ReVision Therapeutics

ReVision Therapeutics Inc. is a company developing drugs for the treatment of age-related macular degeneration. Its products include (Fenretinide), an oral medication that can reduce the accumulation of A2E in the retina and slow the growth of atrophic lesions before vision loss.